Goldman Sachs’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-137,739
Closed -$1.49M – 7085
2026
Q1
$1.49M Hold
137,739
– – ﹤0.01% 4786
2025
Q4
$1.47M Sell
137,739
-84
-0.1% -$895 ﹤0.01% 4845
2025
Q3
$1.46M Buy
137,823
+399
+0.3% +$4.22K ﹤0.01% 4748
2025
Q2
$1.45M Hold
137,424
– – ﹤0.01% 4425
2025
Q1
$1.41M Hold
137,424
– – ﹤0.01% 4425
2024
Q4
$1.39M Buy
137,424
+75,578
+122% +$763K ﹤0.01% 4581
2024
Q3
$623K Buy
+61,846
New +$620K ﹤0.01% 4929

Other funds holding GPAT

Goldman Sachs's GPAT Position: Q2 2026 in Review

Goldman Sachs sold out of GP-Act III Acquisition Corp (GPAT) in Q2 2026, closing a stake of 137,739 shares — an estimated $1.49M sold.

Goldman Sachs first reported a position in GPAT in Q3 2024 and held it in 7 quarters. The position peaked at $1.49M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • Goldman Sachs reported no remaining GP-Act III Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 137,739 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $1.49M.
  • Goldman Sachs first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 7 quarters.
  • Goldman Sachs's GP-Act III Acquisition Corp position peaked at $1.49M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.